|
NAA30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.89710000001398E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.61969999985013E-07 |
| Normal-vs-Stage2 |
2.007600E-02 |
| Normal-vs-Stage3 |
2.396600E-01 |
| Normal-vs-Stage4 |
6.968100E-02 |
| Stage1-vs-Stage2 |
7.628000E-01 |
| Stage1-vs-Stage3 |
1.586190E-01 |
| Stage1-vs-Stage4 |
7.367400E-01 |
| Stage2-vs-Stage3 |
4.454200E-01 |
| Stage2-vs-Stage4 |
6.166200E-01 |
| Stage3-vs-Stage4 |
3.177000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77639999998647E-06 |
| Normal-vs-AfricanAmerican |
4.956200E-04 |
| Normal-vs-Asian |
5.856200E-01 |
| Caucasian-vs-AfricanAmerican |
9.287200E-01 |
| Caucasian-vs-Asian |
6.316800E-01 |
| AfricanAmerican-vs-Asian |
6.035800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.52600000097914E-08 |
| Normal-vs-Female |
4.480200E-02 |
| Male-vs-Female |
5.429800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.433100E-04 |
| Normal-vs-Extreme_Weight |
1.65949999997306E-06 |
| Normal-vs-Obese |
2.220200E-02 |
| Normal-vs-Extreme_Obese |
1.013760E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.222600E-01 |
| Normal_Weight-vs-Obese |
1.803630E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.048600E-01 |
| Extreme_Weight-vs-Obese |
8.886400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.543200E-01 |
| Obese-vs-Extreme_Obese |
5.070400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.411800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.435200E-03 |
| Normal-vs-Age(61-80Yrs) |
9.76420000409206E-08 |
| Normal-vs-Age(81-100Yrs) |
2.040300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.123800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.079040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.165760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.194000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.597190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.447600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.53680000000356E-05 |
| Normal-VS-Type2 PRCC |
1.5614499999983E-05 |
| Normal-VS-KIRP CIMP |
8.370800E-01 |
| Normal-VS-Unclassified PRCC |
5.516000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.922040E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.557000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.381600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.207560E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.166200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.593800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.66479999955216E-07 |
| Normal-vs-N1 |
6.813400E-01 |
| Normal-vs-N2 |
1.33160000004295E-06 |
| N0-vs-N1 |
2.486300E-02 |
| N0-vs-N2 |
2.324400E-01 |
| N1-vs-N2 |
7.644100E-02 |
|
|
